Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) Revenue: 2023-2024

Historic Revenue for Upstream Bio (UPB) over the last 2 years, with Dec 2024 value amounting to $2.4 million.

  • Upstream Bio's Revenue rose 12.52% to $683,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 26.82%. This contributed to the annual value of $2.4 million for FY2024, which is 0.42% down from last year.
  • Per Upstream Bio's latest filing, its Revenue stood at $2.4 million for FY2024, which was down 0.42% from $2.4 million recorded in FY2023.
  • In the past 5 years, Upstream Bio's Revenue ranged from a high of $2.4 million in FY2023 and a low of $2.4 million during FY2024.
  • For the 2-year period, Upstream Bio's Revenue averaged around $2.4 million, with its median value being $2.4 million (2023).
  • Data for Upstream Bio's Revenue shows a maximum YoY dropped of 0.42% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Upstream Bio's Revenue stood at $2.4 million in 2023, then declined by 0.42% to $2.4 million in 2024.